Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

BRAF pseudogene induces cancer

The in vivo role of many pseudogenes remains largely unexplored, especially in cancer. Pier Paolo Pandolfi and colleagues show that overexpression of the Braf pseudogene Braf-rs1 in mice causes the development of an aggressive malignancy similar to human diffuse large B cell lymphoma (Cell doi:10.1016/j.cell.2015.02.043; 2 April 2015). Their data suggest that the oncogenic potential of both Braf-rs1 and its human ortholog, BRAFP1, is based on the function of their transcripts as competitive endogenous RNAs (ceRNAs). Indeed, BRAFP1 seems to function as a sponge, sequestering microRNAs that target BRAF. As a consequence of elevated BRAFP1 levels, BRAF is also upregulated, leading to the activation of MAPK signaling and increased cell proliferation. Importantly, BRAFP1 is often altered in several human cancer types on a genomic or transcriptional level. This work provides an interesting example of a pseudogene involved in disease progression and proposes a ceRNA-mediated mechanism that underpins cancer development.


Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Faial, T. BRAF pseudogene induces cancer. Nat Genet 47, 429 (2015).

Download citation


Quick links